Navigation Links
Cord Blood America Retires $2.53M Obligation
Date:8/5/2009

SANTA MONICA, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today it has retired $2.53M of long-term debt.

"The two notes signed in February and March of 2007 respectively, between CBAI and the Shelter Island Opportunity Fund (SIOF), have been retired as of August 3, 2009. With this debt retirement, CBAI has only the put option agreement obligation with SIOF remaining on its balance sheet. Cord Blood America regards this as a key milestone on its path to being able to operate debt free," said Matthew Schissler, Cord Blood America Founder and CEO. "Shelter Island provided us with the capital to purchase CorCell, which is the first licensed family cord blood banking company in the United States. Using their financing allowed us to establish CBAI as one of the largest domestic stem cell storage companies. Our obligation was to pay the notes in full before the February 28, 2010 maturity date. We are happy to have met the obligation and have saved a significant amount of interest payments because of early payoff."

"We have repeatedly said that decreasing debt would be one of our significant items to focus on in 2009," said Mr. Schissler. "Eliminating debt makes our financial balance sheet stronger and makes Cord Blood America a better investment. We are very pleased with this development."

About Cord Blood America

Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Stem Cell Cord Blood Banking Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.
2. Cellular Dynamics International Reprograms Blood Cells into Stem Cells
3. Cord Blood America Secured $7.5 Million Investment For Series A Preferred Stock
4. Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood-Based Tests for Key Cancer Mutations
5. Cord Blood America Continues International Expansion
6. Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C
7. Researchers solve bloodcurdling mystery
8. Five Cord Blood Transplant Centers in Catalonia and Valencia Join a Study to Test a New Technique to Treat Leukemia and Lymphoma
9. Cord Blood America Says Debt Reduced $4.194 Million in 2009
10. Prospect Therapeutics, Inc.s GCS-100 Inhibited Blood Vessel Formation in a Variety of Cancer Models
11. Cord Blood America to Hold Conference Call on Thursday May 21st at 11 a.m. Eastern Time to Discuss 2009 First Quarter Results and Corporate Developments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ia/--ShanghaiBiolaxyannouncedthe,ChineseStateFood&...gationalnewdrugapplication(IND)foritsoralinsulinpr...atdiabetes.ThisIND,approvalallowsBiolaxytoinitiate...ordercharacteristicofhighbloodglucoseandpoor,metab...emicro-and,macro-vasculardiseases,lossofvision,kid...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/-HamiltonThorneLtd.(T...derofadvancedlasersystemsandinstrumentsforthestemc...operationalandfinancialresultsforthethirdquarteren...ewas$1.46millioncomparedwith$1.43millioninQ32008,-...centinQ3,2008,-Netlossreducedto$148,000comparedto$...
(Date:11/24/2009)...wire/--HealthRoboticstodayannounced,thatithasforme...stors.ThisrecentlyformedToronto-basedcompanywillop...market,install,andsupport,HealthRobotics,i.v.Roomo...oductofferingsi.v.STATION(TM),i.v.SOFT(TM),andOMM(...anceonan"asneeded,basis"toitsstrategicpartnerships...
(Date:11/23/2009)...a provocative new study, a University of Utah scie... the major cause of global warming cannot be stab...iety builds the equivalent of one new nuclear powe...re will be any substantial near-term departure fro... emission rates," says the new paper by Tim Garret...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
...oscope Series Positioned at the Center of the Most...Protocols, MELVILLE, N.Y., Nov. 1 Nikon Instrume...y announced the launch of its latest,inverted micr...models, the,new Ti offers improved system speed, i...oscopy as part of a fully-integrated microscope sy...
... Total Revenues of $59.0 Million, Up 46 Percent Ov...2006, - Third Quarter EPS of $0.70 per Basic Shar...ITDASO of $1.26 per Basic Share, or $1.19 per Dilu... SPRING, Md., Nov. 1 United,Therapeutics Corporat...f,operations for the quarter ended September 30, 2...
...pects to have all Phase 3 data available by spring...authorization applications by fall 2009 -, ROCKVI...aq: HGSI ) today announced that it has completed ... ACHIEVE 2/3, the second of two pivotal,global Pha...) in,combination with ribavirin in treatment-naive...
Other Biology Technology:Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting 2Nikon Unveils the Eclipse Ti Inverted Microscope Series at The Society for Neroscience Annual Meeting 3United Therapeutics Reports Third Quarter 2007 Financial Results 2United Therapeutics Reports Third Quarter 2007 Financial Results 3United Therapeutics Reports Third Quarter 2007 Financial Results 4United Therapeutics Reports Third Quarter 2007 Financial Results 5United Therapeutics Reports Third Quarter 2007 Financial Results 6United Therapeutics Reports Third Quarter 2007 Financial Results 7United Therapeutics Reports Third Quarter 2007 Financial Results 8United Therapeutics Reports Third Quarter 2007 Financial Results 9Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 2Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 3Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 4Human Genome Sciences Completes Enrollment Ahead of Schedule in Second Phase 3 Albuferon(R) Trial 5
(Date:11/23/2009)...A new study by the Wildlife Conservation Society s...e swamp in the Republic of Congopart of the "mothe...ast yearare becoming increasingly threatened by gr... recommends protection of the swamp forests adjace...erve after recent surveys confirmed that high dens...
(Date:11/23/2009)...AMES, Iowa - The only swine vaccine available for ...herd infected with the virus. The vaccination mark...herd diagnosed with the pandemic flu., Iowa Stat...ience, developed the vaccine this summer and has b...n Iowa, Kansas and Illinois for several weeks., ...
(Date:11/23/2009)...DURHAM, N.H. University of New Hampshire microbio... $498,115 to advance understanding of the actinorh...l to enrich nutrient-poor and contaminated soils. ...USDA) awarded Tisa, a professor of molecular, cell...the symbiotic relationship between the bacteria Fr...
Breaking Biology News(10 mins):A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 1PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 3Gilbert Hospital to Begin Dialysis Care 5226 1SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 1SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 2SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 3
...ted by fat cells that plays an important role in f...in a cold-blooded vertebrate, the South African cl...er mammals, leptin acts on the frog brain to suppr... role in the complex signaling that turns a finned...ert Denver, an associate professor of biology at t...
...miliar, even if the products aren,t: biofuel, biob...that,s made from bio-produced materials such as pl...assistant professor of cropping systems at the Cen...t., and his collaborators are investigating Montan...s," which refers to all biologically produced mate...
...iate Professor Barbara Fazekas de St. Groth, a lea...monstrated for the firsttime the important role of...in humans. , In a study involving 38 patients with...ommon forms of inflammatory bowel disease (IBD), a...leagues found that healthy individuals have up tot...
Other Biology News:Leptin found to control appetite and limb development in frogs 2Biofuels researcher searches for new sources 2Biofuels researcher searches for new sources 3Prevention is the best option: fighting autoimmune diseases 2
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
SUPERaseIn from Ambion
...atively supercoiled DNA in presence of EDTA ,App... on transcription in vitro , Studying chromatin r...f supercoiling of naturally occurring DNA , Detec... one base-pair , Increasing restriction endonucle...
Strandase ssDNA Preparation Kit from Novagen
Biology Products: